Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle. (2016)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1096/fj.201600450R

PubMed Identifier: 27550965

Publication URI: http://europepmc.org/abstract/MED/27550965

Type: Journal Article/Review

Volume: 30

Parent Publication: FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Issue: 11

ISSN: 0892-6638